Responses to carboplatin in BRCA1/2-mutated breast cancer

被引：3
|
作者：
Burki, Talha Khan
机构：
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 07期
关键词：
D O I：
10.1016/S1470-2045(18)30407-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E337 / E337
页数：1
相关论文
共 50 条
  • [41] Veliparib, Carboplatin, and Paclitaxel in Patients with BRCA-mutated Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (01)
  • [42] Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    Glodzik, Dominik
    Bosch, Ana
    Hartman, Johan
    Aine, Mattias
    Vallon-Christersson, Johan
    Reutersward, Christel
    Karlsson, Anna
    Mitra, Shamik
    Nimeus, Emma
    Holm, Karolina
    Hakkinen, Jari
    Hegardt, Cecilia
    Saal, Lao H.
    Larsson, Christer
    Malmberg, Martin
    Ryden, Lisa
    Ehinger, Anna
    Loman, Niklas
    Kvist, Anders
    Ehrencrona, Hans
    Nik-Zainal, Serena
    Borg, Ake
    Staaf, Johan
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [43] Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    Dominik Glodzik
    Ana Bosch
    Johan Hartman
    Mattias Aine
    Johan Vallon-Christersson
    Christel Reuterswärd
    Anna Karlsson
    Shamik Mitra
    Emma Niméus
    Karolina Holm
    Jari Häkkinen
    Cecilia Hegardt
    Lao H. Saal
    Christer Larsson
    Martin Malmberg
    Lisa Rydén
    Anna Ehinger
    Niklas Loman
    Anders Kvist
    Hans Ehrencrona
    Serena Nik-Zainal
    Åke Borg
    Johan Staaf
    Nature Communications, 11
  • [44] Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial
    Litton, J. K.
    Hurvitz, S. A.
    Mina, L. A.
    Rugo, H. S.
    Lee, K-H
    Goncalves, A.
    Diab, S.
    Woodward, N.
    Goodwin, A.
    Yerushalmi, R.
    Roch, H.
    Im, Y-H
    Eiermann, W.
    Quek, R. G. W.
    Usari, T.
    Lanzalone, S.
    Czibere, A.
    Blum, J. L.
    Martin, M.
    Ettl, J.
    ANNALS OF ONCOLOGY, 2020, 31 (11) : 1526 - 1535
  • [45] BRCA1 and BRCA2– breast cancer susceptibility genes
    W. Hofmann
    P. M. Schlag
    Journal of Cancer Research and Clinical Oncology, 2000, 126 : 487 - 496
  • [46] BRCA1 and BRCA2 in Indian Breast Cancer Patients
    Saxena, Sunita
    Szabo, Csilla I.
    Chopin, Sandrine
    Barjhoux, Laure
    Sinilnikova, Olga
    Lenoir, Gilbert
    Goldgar, David E.
    Bhatanager, Dinesh
    HUMAN MUTATION, 2002, 20 (06) : 473 - 474
  • [47] BRCA1 and BRCA2 -: breast cancer susceptibility genes
    Hofmann, W
    Schlag, PM
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (09) : 487 - 496
  • [48] BRCA1 and BRCA2 and breast cancer incidence: A review
    Bishop, DT
    ANNALS OF ONCOLOGY, 1999, 10 : 113 - 119
  • [49] Breast cancer susceptibility genes -: BRCA1 and BRCA2
    Brody, LC
    Biesecker, BB
    MEDICINE, 1998, 77 (03) : 208 - 226
  • [50] Highlight: BRCA1 and BRCA2 proteins in breast cancer
    Daniel, DC
    MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 59 (01) : 68 - 83
12345